MedTrace Logo

Interface Selection for Adaptive Servo Ventilation

NCT02919930 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-07-03

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of nasal and oronasal interfaces during ASV treatment on sleep efficiency and sleep architecture. Therefore, patients starting treatment with ASV, will be randomized between two groups. In the first group, patients will use a nasal interface during the first night and an oronasal interface during the second night. In the second group, patients will use an oronasal mask first and a nasal mask during the second night. The results of this trial will have major impact on future clinical practice as it would deliver prediction rules to choose the correct interface immediately.

Conditions

  • Central Sleep Apnea
  • ASV

Interventions

DEVICE

Switch from oronasal to nasal mask during ASV treatment

One night of ASV treatment with oronasal mask followed by one night of ASV treatment with nasal mask.

DEVICE

Switch from nasal to oronasal mask during ASV treatment

One night of ASV treatment with nasal mask followed by one night of ASV treatment with oronasal mask.

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02919930 on ClinicalTrials.gov